International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Latest Content
The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.
Advertisement
Advertisement
Trending on CURE
1
New Combination Treatment Approach Studied in Pancreatic Cancer
2
Why Is Lung Health Key to Survivorship After Cancer Treatment?
3
U.S. Soccer Legend Kasey Keller Reveals Lymphoma Journey
4
FDA Updates Safety Warnings for Common Chemotherapy Drugs
5